#JACCIMG #cvImaging pearl: LV "fat-bite" pattern on #whyCMR has a high specificity for diagnosis of arrhythmogenic right ventricular #cardiomyopathy. bit.ly/4e1Bo3U Babken Asatryan, MD, PhD Stefan Zimmerman #ARVC

📢#Europace #Epeeps #Cardiotwitter Disparities in the access to atrial fibrillation ablation in Denmark 🇩🇰 🤔Gender? Age? Education? Employment? 📑doi.org/10.1093/europa… Giulio Conte Francesco Santoro, MD, PhD Marco Vitolo Ⓜ️ Dominik Linz Xiaodong Zhang (Andy), MD, PhD, FHRS, FACC Luigi Di Biase Boriani Giuseppe

SPIRRIT-HFpEF - study design: - First R-RCT in heart failure - HF w/ LVEF ≥40% - Open label spironolactone/eplerenone vs. usual care - ~2,400 pts - Primary outcome: CV death + total HHF - Results expected 2026/27 onlinelibrary.wiley.com/doi/full/10.10…

How do ECG changes relate to ARVC? ECG abnormalities, like T-wave inversion, evolve over time and are linked to higher risk of ventricular arrhythmias, highlighting the progressive nature of ARVC. #AHAJournals Marianne Tétreault-Langlois Julia CadrinTourigny ahajrnls.org/3XLYlSI

Well done to Alessio Gasperetti, MD PhD and colleagues for putting the largest DSP cohort together! DSP cardiomyopathy is increasingly recognized as a separate clinical entity and marks the significance of the gene-first approach in cardiomyopathies. academic.oup.com/eurheartj/arti…

Abstract and clinical cases submissions for #EHRA2025 are now open! 🚀 Share your breakthrough research with us here 👉 bit.ly/3B501Oq The call is open until the 7th of November for abstracts and the 19th of November for clinical cases 🗓️

Exciting symposium on arrhythmogenic cardiomyopathy (#ACM #ARVC). Working towards gene-specific criteria with many of my great colleagues on day 1: Julia CadrinTourigny Hugh Calkins Ardan M. Saguner, MD Cristina Basso Mario Delmar Chantal van Opbergen Kristina Haugaa Juan Pablo Kaski

Another day working towards gene-specific criteria for #ARVC #ACM arrythmogenic cardiomyopathy in Zurich. This morning PKP2 DSG2 DSC2 DSP PLN and TMEM43 Cardiology USZ

SGLT2 inhibitors are recommended for many people with #heartfailure, #cvCAD and more. The #CardioSmart infographic – What are SGLT2 inhibitors? – helps patients understand the benefits of this class of drugs, possible side effects and more. bit.ly/484rLhf #ACCLATAM

Very grateful to the international #ARVC team, led by Hugh Calkins and Firat Duru, for bringing together the most expert scientific community to share their knowledge. Very proud of our contribution! #ACM #SCD

In 2019, our hypertrophic cardiomyopathy gene curation showed 2/3 of "HCM" genes had ltd/no evidence, with 8 sarcomere genes being key We are excited to share the ClinGen HCM re-appraisal > with 29 genes to be included! medrxiv.org/content/10.110…

🔴 Contemporary approach to cardiogenic shock care: a state-of-the-art #2024Review #openaccess frontiersin.org/articles/10.33… #CardioTwitter #lipid #Cardiology #cardioEd #CardioEd #CardioTwitter #cardiology #MedEd #medtwitter

Large nationwide registry of post-MI pts with LVEF ≤ 35% who were implanted with an ICD after being prescribed a wearable cardioverter–defibrillator provides novel insights into arrhythmic risk. doi.org/10.1093/eurhea… #ICD #MI #cardiotwitter, European Society of Cardiology Journals, European Society of Cardiology

#GCOS2024 #JACCCardioOnc SimPub: #SGLT2i administration was associated with a significantly decreased risk of developing cancer therapy-related cardiac dysfunction in patients with #T2DM and cancer. bit.ly/4ebDU7t #GCOS24 #CardioOnc #Diabetes #T2D Ammar Bhatti DO

#EPeeps #ACNAPTopicOfTheMonth Between 2010 and 2019, the global 🌎 prevalence of #AFib has risen markedly 📈 from 33.5 million to 59 million individuals! Read also our recent The Lancet Reg Health-Europe manuscript: 📖 thelancet.com/journals/lanep… MonikaGawalko Konstanze Betz Jeroen Hendriks

#EHRAtopicweek on Gender Differences in EP ♂️♀️ Listen to the latest #EHRA_ESC Cardio Talk episode! 🎙️ Join experts JK Han MD & David Duncker as they discuss this topic from both the patient’s and the physician’s perspectives 👉bit.ly/3XNHzAP #EPeeps

#EHRA_ESC is conducting a survey on Lifestyle and risk factor modification in #AFib 📃 Share 🫵 thoughts, opinion and experience on this important topic! #EPeeps European Society of Cardiology surveymonkey.com/r/LFRM_SoMe

#EHRA_ESC Call for joint sessions extended deadline until 30 October! #EHRA_ESC collaborates with EP National Cardiac Societies, WGs and associations to reduce the impact of cardiac arrhythmias in 🇪🇺 Be part of this exchange! Find out more 👉 bit.ly/4819TVC European Society of Cardiology

#EHRAweekendreads Lifestyle management for AF – focus on obesity management See ESC consensus document on obesity and cardiovascular disease in EHJ 👇 bit.ly/4eRlrNR #EHRA_ESC #EHRA_Ecomm #EPeeps EHJ Editor-in-Chief

Atrial fibrillation: what patients need to know This new document provides a summary of the key aspects of the guidelines. It has been developed so patients can take an active part in the care they receive for their AF and understand why they are receiving a range of